764 related articles for article (PubMed ID: 24445517)
1. Molecular analysis of circulating tumour cells-biology and biomarkers.
Krebs MG; Metcalf RL; Carter L; Brady G; Blackhall FH; Dive C
Nat Rev Clin Oncol; 2014 Mar; 11(3):129-44. PubMed ID: 24445517
[TBL] [Abstract][Full Text] [Related]
2. Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells.
Keller L; Pantel K
Nat Rev Cancer; 2019 Oct; 19(10):553-567. PubMed ID: 31455893
[TBL] [Abstract][Full Text] [Related]
3. Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.
Morrow CJ; Trapani F; Metcalf RL; Bertolini G; Hodgkinson CL; Khandelwal G; Kelly P; Galvin M; Carter L; Simpson KL; Williamson S; Wirth C; Simms N; Frankliln L; Frese KK; Rothwell DG; Nonaka D; Miller CJ; Brady G; Blackhall FH; Dive C
Ann Oncol; 2016 Jun; 27(6):1155-1160. PubMed ID: 27013395
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of CTCs with diagnostic precision: opportunities and challenges for personalized medicine.
Alberter B; Klein CA; Polzer B
Expert Rev Mol Diagn; 2016; 16(1):25-38. PubMed ID: 26567956
[TBL] [Abstract][Full Text] [Related]
5. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
[TBL] [Abstract][Full Text] [Related]
6. Circulating tumor cell-derived organoids: Current challenges and promises in medical research and precision medicine.
Praharaj PP; Bhutia SK; Nagrath S; Bitting RL; Deep G
Biochim Biophys Acta Rev Cancer; 2018 Apr; 1869(2):117-127. PubMed ID: 29360544
[TBL] [Abstract][Full Text] [Related]
7. The Epigenetic landscape of Circulating tumour cells.
Vasantharajan SS; Eccles MR; Rodger EJ; Pattison S; McCall JL; Gray ES; Calapre L; Chatterjee A
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188514. PubMed ID: 33497709
[TBL] [Abstract][Full Text] [Related]
8. Viable circulating tumour cell detection using multiplex RNA in situ hybridisation predicts progression-free survival in metastatic breast cancer patients.
Payne RE; Wang F; Su N; Krell J; Zebrowski A; Yagüe E; Ma XJ; Luo Y; Coombes RC
Br J Cancer; 2012 May; 106(11):1790-7. PubMed ID: 22538972
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumour cells in metastatic head and neck cancers.
Kulasinghe A; Perry C; Jovanovic L; Nelson C; Punyadeera C
Int J Cancer; 2015 Jun; 136(11):2515-23. PubMed ID: 25111594
[TBL] [Abstract][Full Text] [Related]
10. Profiling circulating tumour cells and other biomarkers of invasive cancers.
Poudineh M; Sargent EH; Pantel K; Kelley SO
Nat Biomed Eng; 2018 Feb; 2(2):72-84. PubMed ID: 31015625
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumour cells in the -omics era: how far are we from achieving the 'singularity'?
Visal TH; den Hollander P; Cristofanilli M; Mani SA
Br J Cancer; 2022 Jul; 127(2):173-184. PubMed ID: 35273384
[TBL] [Abstract][Full Text] [Related]
12. Characterizing the Cancer Genome in Blood.
Dawson SJ
Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29844219
[TBL] [Abstract][Full Text] [Related]
13. Circulating tumor cell enumeration with a combination of epithelial cell adhesion molecule- and cell-surface vimentin-based methods for monitoring breast cancer therapeutic response.
Satelli A; Brownlee Z; Mitra A; Meng QH; Li S
Clin Chem; 2015 Jan; 61(1):259-66. PubMed ID: 25336717
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cell as the functional aspect of liquid biopsy to understand the metastatic cascade in solid cancer.
Cortés-Hernández LE; Eslami-S Z; Alix-Panabières C
Mol Aspects Med; 2020 Apr; 72():100816. PubMed ID: 31377345
[TBL] [Abstract][Full Text] [Related]
15. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
16. Genetic traits for hematogeneous tumor cell dissemination in cancer patients.
Joosse SA; Pantel K
Cancer Metastasis Rev; 2016 Mar; 35(1):41-8. PubMed ID: 26931653
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of single circulating tumour cells following long-term storage of clinical samples.
Mesquita B; Rothwell DG; Burt DJ; Chemi F; Fernandez-Gutierrez F; Slane-Tan D; Antonello J; Carter M; Carter L; Parry M; Franklin L; Marais R; Blackhall F; Dive C; Brady G
Mol Oncol; 2017 Dec; 11(12):1687-1697. PubMed ID: 28741788
[TBL] [Abstract][Full Text] [Related]
18. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy.
Schlange T; Pantel K
Pharmacogenomics; 2016 Feb; 17(3):183-6. PubMed ID: 26799583
[No Abstract] [Full Text] [Related]
19. Clinical applications of the CellSearch platform in cancer patients.
Riethdorf S; O'Flaherty L; Hille C; Pantel K
Adv Drug Deliv Rev; 2018 Feb; 125():102-121. PubMed ID: 29355669
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of circulating tumor cells-from bench to bedside.
Li Y; Wu S; Bai F
Semin Cell Dev Biol; 2018 Mar; 75():88-97. PubMed ID: 28899718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
